AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

But it's not all bad news. A PET scan of a female patient with breast cancer, which has spread to the lymph nodes, bones and liver. In its recent annual report, the American Cancer Society shared ...

Dr Salatzki received honoraria for lectures from Roche Diagnostics, AstraZeneca, Bayer, Daiichi Sankyo, and Lilly Eli Deutschland. He serves as a consultant for Roche Diagnostics, BRAHMS Thermo Fisher ...

The blockbuster drug Enhertu from AstraZeneca and Japanese drugmaker Daiichi Sankyo stalled the growth of a common type of breast cancer by more than a year in a large late-stage trial when used ...

HER2-negative breast cancer. AstraZeneca (NASDAQ:AZN) is a biopharmaceutical company that discovers, develops, and commercializes prescription medicines. Whereas Daiichi Sankyo Company Limited ...